Tag : VTE

Neurology

FDA OKs Dalteparin (Fragmin), First Anticoagulant for Pediatric VTE

Newsemia
The low-molecular-weight heparin is indicated to reduce the recurrence of symptomatic venous thromboembolism in children as young as 1 month. FDA Approvals Source link...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy